X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (31364) 31364
Publication (2110) 2110
Book Review (623) 623
Magazine Article (118) 118
Book Chapter (101) 101
Book / eBook (56) 56
Conference Proceeding (48) 48
Newsletter (37) 37
Reference (16) 16
Web Resource (11) 11
Dissertation (7) 7
Trade Publication Article (6) 6
Data Set (3) 3
Newspaper Article (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (24395) 24395
male (14299) 14299
adrenergic beta-antagonists - therapeutic use (11059) 11059
female (10978) 10978
index medicus (8649) 8649
animals (8001) 8001
middle aged (7720) 7720
adult (6247) 6247
aged (6121) 6121
pharmacology & pharmacy (5502) 5502
hypertension - drug therapy (3783) 3783
treatment outcome (3768) 3768
rats (3545) 3545
cardiac & cardiovascular systems (3541) 3541
antihypertensive agents - therapeutic use (3195) 3195
drug therapy, combination (3120) 3120
adrenergic beta-agonists - therapeutic use (2963) 2963
angiotensin-converting enzyme inhibitors - therapeutic use (2701) 2701
blood pressure - drug effects (2490) 2490
asthma - drug therapy (2345) 2345
adrenergic beta-antagonists - pharmacology (2310) 2310
drug therapy (2261) 2261
calcium channel blockers - therapeutic use (2212) 2212
time factors (2196) 2196
dose-response relationship, drug (2173) 2173
double-blind method (2113) 2113
heart rate - drug effects (2107) 2107
risk factors (2018) 2018
hypertension (2016) 2016
medicine, general & internal (1958) 1958
heart failure - drug therapy (1939) 1939
mortality (1854) 1854
adrenergic alpha-antagonists - therapeutic use (1853) 1853
adolescent (1821) 1821
bronchodilator agents - therapeutic use (1774) 1774
neurosciences (1765) 1765
care and treatment (1702) 1702
diuretics - therapeutic use (1629) 1629
child (1565) 1565
double-blind (1549) 1549
heart failure (1548) 1548
vasodilator agents - therapeutic use (1518) 1518
asthma (1500) 1500
aged, 80 and over (1492) 1492
adrenergic beta-antagonists - adverse effects (1466) 1466
clinical trials as topic (1439) 1439
respiratory system (1434) 1434
analysis (1386) 1386
adrenergic beta-antagonists - administration & dosage (1384) 1384
anti-arrhythmia agents - therapeutic use (1373) 1373
administration, inhalation (1329) 1329
medicine & public health (1319) 1319
prospective studies (1300) 1300
psychiatry (1289) 1289
therapy (1288) 1288
propanolamines - therapeutic use (1275) 1275
randomized controlled trials as topic (1264) 1264
research (1193) 1193
in vitro techniques (1186) 1186
retrospective studies (1184) 1184
hemodynamics - drug effects (1177) 1177
mice (1174) 1174
management (1147) 1147
hypertension - physiopathology (1122) 1122
health aspects (1118) 1118
follow-up studies (1115) 1115
adrenergic beta-agonists - pharmacology (1083) 1083
electrocardiography (1074) 1074
rats, sprague-dawley (1070) 1070
adrenergic alpha-antagonists - pharmacology (1010) 1010
propranolol - therapeutic use (1004) 1004
beta-blockers (973) 973
efficacy (955) 955
adrenergic beta-agonists - administration & dosage (954) 954
peripheral vascular disease (953) 953
adrenergic alpha-agonists - therapeutic use (935) 935
prognosis (932) 932
abridged index medicus (930) 930
adrenal cortex hormones - therapeutic use (923) 923
propranolol (917) 917
blood pressure (910) 910
rats, wistar (886) 886
myocardial infarction - drug therapy (878) 878
heart failure - physiopathology (871) 871
disease models, animal (868) 868
pulmonary disease, chronic obstructive - drug therapy (866) 866
internal medicine (860) 860
risk (860) 860
drug interactions (851) 851
article (840) 840
carvedilol (836) 836
adrenergic beta blockers (835) 835
cardiology (834) 834
anti-asthmatic agents - therapeutic use (830) 830
chronic disease (824) 824
albuterol - therapeutic use (818) 818
clinical neurology (815) 815
urology & nephrology (811) 811
drugs (810) 810
hypertension - complications (805) 805
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (28609) 28609
German (752) 752
French (612) 612
Russian (413) 413
Italian (245) 245
Japanese (233) 233
Spanish (210) 210
Polish (118) 118
Dutch (65) 65
Danish (49) 49
Hungarian (44) 44
Chinese (40) 40
Romanian (39) 39
Swedish (37) 37
Norwegian (32) 32
Czech (31) 31
Portuguese (28) 28
Finnish (27) 27
Bulgarian (17) 17
Lithuanian (12) 12
Turkish (11) 11
Hebrew (10) 10
Serbian (7) 7
Slovak (7) 7
Croatian (5) 5
Ukrainian (5) 5
Arabic (2) 2
Korean (2) 2
Icelandic (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2011, Volume 378, Issue 9798, pp. 1231 - 1243
Summary Background Although most cardiovascular disease occurs in low-income and middle-income countries, little is known about the use of effective secondary... 
Internal Medicine | STROKE | MEDICINE, GENERAL & INTERNAL | RISK-FACTORS | THERAPY | MYOCARDIAL-INFARCTION | AVAILABILITY | HEART-FAILURE | SELF-REPORT | ACUTE CORONARY SYNDROMES | MEDICINES | VALIDITY | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Data Collection | Secondary Prevention | Stroke - drug therapy | Urban Population | Antihypertensive Agents - therapeutic use | Drug Utilization | Cardiovascular Agents - therapeutic use | Developed Countries | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Rural Population | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Coronary Disease - drug therapy | Adult | Female | Aged | Developing Countries | Platelet Aggregation Inhibitors - therapeutic use | Adrenergic beta-Antagonists - therapeutic use | Care and treatment | Research | Cardiovascular diseases | Health aspects | Cardiovascular agents | Studies | Low income groups | Stroke | Households | Socioeconomic factors | Data collection | Cardiovascular disease | Epidemiology | Economic development | Community | Drug use | Antihypertensive Agents/therapeutic use | Angiotensin-Converting Enzyme Inhibitors/therapeutic use | Cardiovascular Agents/therapeutic use | Coronary Disease/drug therapy | Cardiovascular Diseases/prevention & control | Platelet Aggregation Inhibitors/therapeutic use | Stroke/drug therapy | MEDICIN OCH HÄLSOVETENSKAP | Adrenergic beta-Antagonists/therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use | MEDICAL AND HEALTH SCIENCES
Journal Article
Journal Article
1997, Lung biology in health and disease, ISBN 9780824794965, Volume 106., xvi, 443
Book
Journal of the National Cancer Institute, ISSN 0027-8874, 1/2010, Volume 102, Issue 1, pp. 14 - 25
Due to the aging of the populations of developed countries and a common occurrence of risk factors, it is increasingly probable that a patient may have both... 
DOXORUBICIN-INDUCED CARDIOTOXICITY | TRASTUZUMAB-RELATED CARDIOTOXICITY | ONCOLOGY | SPORADIC COLORECTAL ADENOMAS | VASCULAR-DISRUPTING AGENTS | TYROSINE KINASE INHIBITOR | N-ACETYLCYSTEINE | DAUNORUBICIN-INDUCED CYTOTOXICITY | HIGH-DOSE CHEMOTHERAPY | EARLY BREAST-CANCER | ATRIAL-FIBRILLATION | Atrial Fibrillation - chemically induced | Cardiovascular Diseases - prevention & control | Humans | Patient Care Team | Atrial Fibrillation - physiopathology | Ventricular Dysfunction, Left - chemically induced | Flavonoids - therapeutic use | Cardiotonic Agents - therapeutic use | Venous Thromboembolism - prevention & control | Cardiovascular System - physiopathology | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Antineoplastic Agents - adverse effects | Hypertension - chemically induced | Hypertension - prevention & control | Polyphenols | Free Radical Scavengers - therapeutic use | Acetylcysteine - therapeutic use | Platelet Aggregation Inhibitors - therapeutic use | Adrenergic beta-Antagonists - therapeutic use | Cardiovascular Diseases - diagnosis | Heart - physiopathology | Cardiovascular Diseases - physiopathology | Stroke Volume - drug effects | Anticoagulants - therapeutic use | Cardiovascular System - drug effects | Hypertension - physiopathology | Ventricular Dysfunction, Left - physiopathology | Ventricular Dysfunction, Left - prevention & control | Cardiovascular Diseases - microbiology | Animals | Blood Coagulation - drug effects | Venous Thromboembolism - physiopathology | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Phenols - therapeutic use | Venous Thromboembolism - chemically induced | Heart - drug effects | Cardiovascular Diseases - chemically induced | Atrial Fibrillation - prevention & control | Antimitotic agents | Complications and side effects | Aging | Physiological aspects | Dosage and administration | Research | Cardiovascular diseases | Antineoplastic agents | Risk factors | Index Medicus | Review
Journal Article
Psychiatry and Clinical Neurosciences, ISSN 1323-1316, 06/2015, Volume 69, Issue 6, pp. 321 - 334
Tardive dyskinesia is a serious, disabling and potentially permanent, neurological hyperkinetic movement disorder that occurs after months or years of taking... 
first‐generation agents | schizophrenia | management | second‐generation agents | tardive dyskinesia | second-generation agents | first-generation agents | VITAMIN-E TREATMENT | NEUROTROPHIC FACTOR LEVELS | SCHIZOPHRENIC-PATIENTS | PSYCHIATRY | GINKGO-BILOBA | CHAIN AMINO-ACIDS | NEUROSCIENCES | ATYPICAL ANTIPSYCHOTICS | CLINICAL NEUROLOGY | HYPERKINETIC MOVEMENT-DISORDERS | DOUBLE-BLIND | PLACEBO-CONTROLLED TRIAL | ESSENTIAL FATTY-ACIDS | Stilbenes - therapeutic use | Antipsychotic Agents - adverse effects | Humans | Propranolol - therapeutic use | Leucine - therapeutic use | Dopamine Agents - therapeutic use | Amantadine - therapeutic use | Piracetam - therapeutic use | Pyridoxine - therapeutic use | Clonazepam - therapeutic use | Drugs, Chinese Herbal - therapeutic use | Adrenergic beta-Antagonists - therapeutic use | Adrenergic Uptake Inhibitors - therapeutic use | Anticonvulsants - therapeutic use | Nootropic Agents - therapeutic use | Isoleucine - therapeutic use | Vitamins - therapeutic use | Ginkgo biloba | alpha-Tocopherol - therapeutic use | Antioxidants - therapeutic use | Movement Disorders - etiology | Piracetam - analogs & derivatives | Melatonin - therapeutic use | Fatty Acids, Omega-3 - therapeutic use | Valine - therapeutic use | Isoxazoles - therapeutic use | Plant Extracts - therapeutic use | Movement Disorders - drug therapy | Tetrabenazine - therapeutic use | Schizophrenia | Movement disorders | Tardive dyskinesia | Medical research
Journal Article
European Heart Journal, ISSN 0195-668X, 03/2003, Volume 24, Issue 5, pp. 464 - 474
Journal Article
Intensive care medicine, ISSN 0342-4642, 2017, Volume 43, Issue 3, pp. 304 - 377
Journal Article